Canacol Energy Ltd (CNNEF)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43	91	180	247	447	529
Market Cap Growth	-38.80%	-49.36%	-27.22%	-44.73%	-15.46%	-18.13%
Enterprise Value	727	710	762	672	804	840
Last Close Price	1.28	2.67	5.30	6.55	10.32	11.41
PE Ratio	1.41	-	2.09	1.68	29.44	-
PS Ratio	0.13	0.24	0.57	0.74	1.44	1.90
PB Ratio	0.12	0.28	0.51	0.85	2.41	2.55
P/TBV Ratio	0.12	0.28	0.51	0.85	2.41	2.55
P/FCF Ratio	-	2.00	-	12.93	17.81	7.91
P/OCF Ratio	0.27	0.54	1.89	1.33	3.61	3.47
EV/Sales Ratio	2.15	1.89	2.41	2.00	2.59	3.01
EV/EBITDA Ratio	2.92	2.59	3.48	3.36	4.48	4.80
EV/EBIT Ratio	4.33	3.73	5.37	6.14	8.49	7.41
EV/FCF Ratio	-10844.38	15.56	-	35.19	32.04	12.58
Debt / Equity Ratio	1.98	2.27	1.92	1.75	2.77	1.88
Debt / EBITDA Ratio	2.90	2.62	3.06	2.52	2.79	2.17
Debt / FCF Ratio	-	15.96	-	26.81	20.42	5.84
Asset Turnover	0.28	0.31	0.28	0.36	0.39	0.37
Inventory Turnover	73.13	98.63	116.55	254.91	178.04	104.32
Quick Ratio	0.50	1.13	0.89	0.68	2.80	1.62
Current Ratio	0.57	1.20	0.92	0.70	2.83	1.66
Return on Equity (ROE)	8.72%	-9.73%	26.80%	61.74%	7.73%	-2.11%
Return on Assets (ROA)	8.68%	9.72%	7.90%	7.37%	7.42%	9.43%
Return on Capital (ROIC)	10.03%	11.46%	9.69%	9.12%	9.14%	11.73%
Return on Capital Employed (ROCE)	15.80%	17.80%	13.30%	13.30%	12.30%	17.30%
Earnings Yield	70.89%	-35.95%	47.97%	59.62%	3.40%	-0.90%
FCF Yield	-0.16%	50.11%	-66.93%	7.73%	5.62%	12.64%
Dividend Yield	-	-	14.86%	11.72%	7.96%	7.16%
Payout Ratio	-	-	30.56%	18.78%	194.10%	-
Buyback Yield / Dilution	-0.02%	-0.00%	0.10%	4.17%	1.39%	-0.14%
Total Shareholder Return	-	-0.00%	14.96%	15.89%	9.35%	7.02%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.